30 results on '"Escandon, Rafael"'
Search Results
2. Somatic Gene Therapy Research in Pediatric Populations: Ethical Issues and Guidance for Operationalizing Early Phase Trials
3. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease
4. A novel prescription digital therapeutic option for the treatment of metabolic dysfunction-associated steatotic liver disease
5. Challenges in accelerated approvals for gene therapies
6. A novel prescription digital therapeutic for the treatment of non-alcohol related fatty liver disease: feasibility study
7. Somatic Gene Therapy Research in Pediatric Populations: Ethical Issues and Guidance for Operationalizing Early Phase Trials
8. Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study
9. Fetal Therapies and Clinical Research: Beyond Risk and Benefit
10. Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
11. The need for ethical and pragmatic strategies for sample and data collection during public health emergencies—minimizing missed opportunities
12. Design of a Phase 1/2 Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy in Adults With Classic Congenital Adrenal Hyperplasia (CAH) Due to 21-hydroxylase Deficiency Through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene
13. FRI-515 - A novel prescription digital therapeutic for the treatment of non-alcohol related fatty liver disease: feasibility study
14. Research in prisoners without proper oversight.
15. Recruitment rates and data quality are they linked? An evaluation of query generation rate as an indicator of major factors influencing data quality
16. Challenges in accelerated approvals for gene therapies
17. The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity inin vivoandin vitromodels of aggressive large B-cell lymphoma
18. Safety and Tolerability of LBR-101, a Humanized Monoclonal Antibody That Blocks the Binding of CGRP to Its Receptor - Results of the Phase 1 Program (P7.190)
19. The IV Pharmaokinetics of Single and Multiple Doses of LBR-101 in Healthy Volunteers (P7.189)
20. Cardiovascular and Hemodynamic Parameters in Women Following IV Administration of LBR-101, a Monoclonal Antibody Against CGRP (P7.198)
21. Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
22. Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer
23. The Novel Kinesin Spindle Protein Inhibitor SB-743921 Exhibits Marked Activity In In Vivo and In Vitro In Models of Aggressive Diffuse Large B-Cell Lymphoma
24. Phase II Safety Study Evaluating the Novel Cardiac Myosin Activator, CK-1827452, in Patients with Ischemic Cardiomyopathy and Angina
25. Oral Bioavailability of the Selective Cardiac Myosin Activator CK-1827452: Chronic Oral Inotropic Therapy for Heart Failure?
26. The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma.
27. The Selective Cardiac Myosin Activator, CK-1827452, Increases Left Ventricular Systolic Function by Increasing Ejection Time: Results of a First-in-Human Study of a Unique and Novel Mechanism
28. Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program.
29. The Novel Kinesin Spindle Protein Inhibitor SB-743921 Exhibits Marked Activity In In Vivoand In VitroIn Models of Aggressive Diffuse Large B-Cell Lymphoma
30. Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.